Compare Medpace Holdings Inc (MEDP) vs Consumer Discretionary Select Sector SPDR Fund (XLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Medpace Holdings Inc trades at $532.42 (market cap $15.08B), while Consumer Discretionary Select Sector SPDR Fund trades at $114.92. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Consumer Discretionary Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| MEDP | XLY | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | — |
52-Week High | $620.59 | $124.52 |
52-Week Low | $308.88 | $105.64 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLY trades at $114.61, down 0.72% on the day, with a bearish technical signal from moving averages but neutral oscillators. Analyst coverage is limited to one buy rating. Recent news highlights its potential as a consumer discretionary play amid mixed economic signals, with a dividend scheduled for June 2026.
The outlook hinges on consumer spending trends; risks include inflation pressures and weak sentiment. The ETF's performance is closely tied to top holdings like Tesla and Amazon, with technical support near $114 offering a key level to watch for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Consumer Discretionary Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.
Read more on XLY →
